|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 213/56 | (2006.01) |
| A61K 31/4418 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3679016 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18854688.1 |
| Date of filing the European patent application | 2018-09-07 | |
| (97) | Date of publication of the European application | 2020-07-15 |
| (45) | Date of publication and mention of the grant of the patent | 2025-11-05 |
| (46) | Date of publication of the claims translation | 2026-02-10 |
| (86) | Number | PCT/US2018/049829 |
| Date | 2018-09-07 |
| (87) | Number | WO 2019/051147 |
| Date | 2019-03-14 |
| (30) | Number | Date | Country code |
| 201762555390 P | 2017-09-07 | US |
| (72) |
SMOLINSKI, Michael P. , US
|
| (73) |
ATNX SPV, LLC ,
161 Bay Street, Suite 5000, Toronto, Ontario M5J 2S1,
CA
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 2-(5-(4-(2-morfolinoetoksi)fenil)piridin-2-IL)-N-benzilacetamido kietosios formos |
| SOLID FORMS OF 2-(5-(4-(2-MORPHOLINOETHOXY)PHENYL)PYRIDIN-2-YL)-N-BENZYLACETAMIDE |